National Survey of Workplace Violence (CMDA-SURVEY1)

National Survey of Workplace Violence Against Chinese Physicians of Obstetrics and Gynecology

China has witnessed a surge in violence against medical personnel, including widely reported incidents of violent abuse, riots, attacks, and protests in hospitals, but little is known about the definite prevalence of workplace violence against physicians of obstetrics and gynecology in China. The aim of this study is to analyze prevalence of workplace violence against physicians of obstetrics and gynecology in China. A customized questionnaire will be delivered by the social software WeChat to the specific hospital which has been randomly sampled, and all physicians of Obstetrics and Gynecology in this hospital will fill the questionnaire anonymously.

A random sampling will be performed in all 32 provinces, municipality or autonomous regions in the mainland of China. It is assumed that acceptable 95% confidence interval is P±4%, and the sample size under the condition of simple random sampling is 600 persons. If the homogeneity is set as 0.15 or 0.2, and each population (unit) has 10 or 15 persons accepting survey, we will achieve a design effect of 2.35 to 3.80. If we choose the design effect of 3, the sample size of every level needs is 1800. Considering 10% population refusing to be surveyed, in all mainland of China, three levels of hospitals will include at least 6000 physicians who accept survey.

Study Overview

• Status: Unknown
• Conditions: Questionnaire; China; Workplace Violence Against Physicians; National Survey; Obstetrics and Gynecology; Random Sample
• Intervention / Treatment: Other: Questionnaire survey

• Study Type: Observational
• Enrollment (Anticipated): 6000

Contacts and Locations

Study Locations

• China
  • Beijing
    • Beijing, Beijing, China, 100730
      • Recruiting
      • Lei Li

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: N/A
• Genders Eligible for Study: All

• Sampling Method: Probability Sample

Study Population

All physicians of obstetrics and gynecology from the hospitals randomly samples

Description

Inclusion Criteria:

• Aged 18 years old
• Belonging to and registered at specific hospital
• Active employment in obstetrics, reproduction, or gynecology
• Signed an approved informed consents

Exclusion Criteria:

• Not meeting all the inclusion criteria
• Not completing the whole questionnaire

Study Plan

How is the study designed?

Number of groups / cohorts

3

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Primary hospital or clinics	Other: Questionnaire survey; A customized questionnaire will be delivered by the social software WeChat to explore the prevalence, potential reasons and solutions of workplace violence against physicians of obstetrics and gynecology in China
Secondary hospital	Other: Questionnaire survey; A customized questionnaire will be delivered by the social software WeChat to explore the prevalence, potential reasons and solutions of workplace violence against physicians of obstetrics and gynecology in China
Tertiary hospital	Other: Questionnaire survey; A customized questionnaire will be delivered by the social software WeChat to explore the prevalence, potential reasons and solutions of workplace violence against physicians of obstetrics and gynecology in China

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Prevalence of workplace violence in all physicians	Percentage of verbal abuse, physical assault and sexual assaults	In past 12 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Potential reasons of workplace violence in all physicians	Percentage of different choices of potential reasons in a customized questionnaire	Two months
Potential solution of workplace violence in all physicians	Percentage of different choices of potential solution in a customized questionnaire	Two months

Collaborators and Investigators

• Sponsor: Lei Li

Study record dates

Study Major Dates

• Study Start (Actual): July 27, 2020
• Primary Completion (Anticipated): September 27, 2020
• Study Completion (Anticipated): September 27, 2020

Study Registration Dates

• First Submitted: July 27, 2020
• First Submitted That Met QC Criteria: July 27, 2020
• First Posted (Actual): July 30, 2020

Study Record Updates

• Last Update Posted (Actual): July 30, 2020
• Last Update Submitted That Met QC Criteria: July 27, 2020
• Last Verified: July 1, 2020

More Information

Terms related to this study

• Other Study ID Numbers: CMDA-SURVEY1

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No